ANAM JAFFAR: Open Payments
NPI 1255986428 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 56 payments from 17 companies in 2025. Trend: 2023 $297 · 2024 $993 · 2025 $1,325
Food & beverage: $1,225Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $263 |
| Novartis Pharmaceuticals Corporation | 6 | $168 |
| GENZYME CORPORATION | 6 | $153 |
| REVANCE THERAPEUTICS, INC. | 1 | $148 |
| ABBVIE INC. | 9 | $139 |
| Lilly USA, LLC | 5 | $110 |
| Regeneron Healthcare Solutions, Inc. | 2 | $77 |
| PFIZER INC. | 3 | $53 |
| E.R. Squibb & Sons, L.L.C. | 2 | $49 |
| Merck Sharp & Dohme LLC | 1 | $24 |
Products named: TREMFYA, DUPIXENT, DAXI, COSENTYX, EBGLYSS, RINVOQ, SKYRIZI, Sotyktu.
Industry payments across FL — which companies pay providers there.
